Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce Biotech
Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce Biotech
Contenu indisponible. Consultez la source originale.
Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce Biotech
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.